Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Xtacy Therapeutics ( (TSE:LOAN) ) has issued an announcement.
Pegasus Mercantile Inc. announced that it has missed the filing deadline for its audited annual financial statements for the year ended September 30, 2024, due to a change in directors and audit procedures following an increase in client base and M&A discussions. The company has obtained a Management Cease Trade Order to allow more time for filing, expecting to complete the process by March 31, 2025, while maintaining alternative information guidelines and limiting trading activities for specific executives.
More about Xtacy Therapeutics
Pegasus Mercantile Inc., formerly known as Xtacy Therapeutics Corp., is involved in the financial services sector, with its shares listed on the Canadian Securities Exchange, Frankfurt Stock Exchange, and OTC markets.
YTD Price Performance: 25.00%
Average Trading Volume: 117,535
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.41M
For a thorough assessment of LOAN stock, go to TipRanks’ Stock Analysis page.